Literature DB >> 27656858

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review.

Anthony Wong1, Andrey Augusto Malvestiti2, Mariana de Figueiredo Silva Hafner3.   

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are uncommon, acute and potentially life-threatening adverse cutaneous drug reactions. These pathologies are considered a hypersensitivity reaction and can be triggered by drugs, infections and malignancies. The drugs most often involved are allopurinol, some antibiotics, including sulfonamides, anticonvulsants such as carbamazepine, and some non-steroid anti-inflammatory drugs (NSAIDs). Necrosis of keratinocytes is manifested clinically by epidermal detachment, leading to scalded skin appearance. The rash begins on the trunk with subsequent generalization, usually sparing the palmoplantar areas. Macular lesions become purplish, and epidermal detachment occurs, resulting in flaccid blisters that converge and break, resulting in extensive sloughing of necrotic skin. Nikolsky's sign is positive in perilesional skin. SJS and TEN are considered to be two ends of the spectrum of one disease, differing only by their extent of skin detachment. Management of patients with SJS or TEN requires three measures: removal of the offending drug, particularly drugs known to be high-risk; supportive measures and active interventions. Early diagnosis of the disease, recognition of the causal agent and the immediate withdrawal of the drug are the most important actions, as the course of the disease is often rapid and fatal.

Entities:  

Mesh:

Year:  2016        PMID: 27656858     DOI: 10.1590/1806-9282.62.05.468

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  9 in total

1.  Stevens-Johnson Syndrome: A Perplexing Diagnosis.

Authors:  Jonathan Dutt; Amit Sapra; Pooja Sheth-Dutt; Priyanka Bhandari; Supriya Gupta
Journal:  Cureus       Date:  2020-03-23

2.  Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.

Authors:  Eric P Borrelli; Erica Y Lee; Andrew M Descoteaux; Stephen J Kogut; Aisling R Caffrey
Journal:  Epilepsia       Date:  2018-11-05       Impact factor: 5.864

3.  Bronchiolitis obliterans due to toxic epidermal necrolysis - a serious condition with a good therapeutic response.

Authors:  Ana Lucíola Borges Pinheiro Façanha; Ricardo Coelho Reis; Rita de Cássia Parente Prado; Jader Fernandes Façanha; Marcelo Alcantara Holanda
Journal:  J Bras Pneumol       Date:  2021-08-11       Impact factor: 2.624

4.  Carbamazepine Induced Stevens-Johnson Syndrome That Developed into Toxic Epidermal Necrolysis: Review of the Literature.

Authors:  Yousef S Abuzneid; Hussam I A Alzeerelhouseini; Duha Rabi; Ihab Hilail; Hatem Rjoob; Abdelrahman Rabee; Naser Amro; Qutaiba Qafisheh; Mohammad Kharraz
Journal:  Case Rep Dermatol Med       Date:  2022-05-06

5.  Treatment of severe drug reactions by hemodialysis.

Authors:  Rokea A El-Azhary; Michael Z Wang; Ashley B Wentworth; LaTonya J Hickson
Journal:  Int J Dermatol       Date:  2017-11-22       Impact factor: 2.736

6.  Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome.

Authors:  Juan F Toledo-Martinez; Ethel V Galdamez-Carcamo; Francisco J Somoza-Cano; Diego A Padilla-Mantilla; Karina L Alvarenga-Alvarado
Journal:  Cureus       Date:  2022-01-18

7.  An Epidemiological Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis during 2010-2015 at Shahid Faghihi Hospital, Shiraz, Iran.

Authors:  Roghayeh Talebi; Nasrin Saki; Hadi Raeisi Shahraki; Seyed Hossein Owji
Journal:  Iran J Med Sci       Date:  2018-07

8.  Hepatic Bioactivation of Skin-Sensitizing Drugs to Immunogenic Reactive Metabolites.

Authors:  Lor Huai Chong; Celine Ng; Huan Li; Edmund Feng Tian; Abhishek Ananthanarayanan; Michael McMillian; Yi-Chin Toh
Journal:  ACS Omega       Date:  2019-08-12

9.  Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.

Authors:  Kazeem Adeola Oshikoya; Ibrahim Abayomi Ogunyinka; Comfort Kunak Ogar; Abiodun Abiola; Ali Ibrahim; Ibrahim Adekunle Oreagba
Journal:  Ther Adv Drug Saf       Date:  2020-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.